Breaking Down Elevance Health Inc. (ELV) Financial Health: Key Insights for Investors

Breaking Down Elevance Health Inc. (ELV) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Healthcare Plans | NYSE

Elevance Health Inc. (ELV) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Are you keeping a close watch on Elevance Health Inc. (ELV) and wondering about its financial stability? With a market capitalization of $89.92 billion, Elevance Health stands as a leading health benefits company in the United States. In 2024, the company reported operating revenue of $175.2 billion, a 3% increase, driven by higher premium yields and growth in CarelonRx product revenue. But how does this translate into overall financial health, and what are the key indicators that investors should be aware of? Dive in to uncover critical insights into Elevance Health's financial performance, debt management, and profitability metrics, providing you with a comprehensive overview for informed investment decisions.

Elevance Health Inc. (ELV) Revenue Analysis

Elevance Health Inc. generates revenue from a variety of sources, primarily through its health insurance and related services. These operations are divided into key segments that contribute to the company's overall financial performance. Understanding these revenue streams provides critical insights into Elevance Health's business model and growth trajectory.

For the fiscal year 2024, Elevance Health reported $170.2 billion in operating revenue. A significant portion of this revenue comes from premiums on risk-based products, reflecting their core business of providing health insurance plans to individuals and employers. Additionally, the company earns revenue from fee-based services, which include administrative services, pharmacy benefit management, and care delivery. These diversified revenue streams help to stabilize Elevance Health's financial performance and reduce reliance on any single market segment.

Elevance Health's revenue growth has demonstrated a consistent upward trend. The company reported the following revenue figures in recent years:

  • 2022: $156 billion
  • 2023: $169.8 billion
  • 2024: $170.2 billion

The year-over-year revenue growth from 2023 to 2024 was approximately 0.24%. This growth rate reflects the company's ability to expand its market presence, increase membership, and capitalize on new opportunities in the healthcare sector. Historical trends indicate that Elevance Health has been successful in maintaining a steady growth rate, driven by strategic initiatives and effective management of its diverse business segments.

Elevance Health operates through several key business segments, each contributing uniquely to the company’s revenue. These segments include:

  • Health Benefits: This segment includes managed care plans and related services.
  • Carelon: Focuses on healthcare services and solutions, including pharmacy, behavioral health, and care delivery.
  • Elevance Health Other: Includes corporate and other activities.

The following table illustrates the contribution of each business segment to Elevance Health's overall revenue for the fiscal year 2024:

Business Segment Revenue (USD Billions) Percentage of Total Revenue
Health Benefits 144.4 84.8%
Carelon 39.3 23.1%
Elevance Health Other (13.5) -7.9%

Significant changes in revenue streams can arise from various factors, including changes in healthcare policy, shifts in market demand, and strategic decisions made by Elevance Health. For example, the expansion of Carelon reflects a strategic move to diversify revenue sources and capitalize on the growing demand for integrated healthcare solutions. Monitoring these changes is crucial for investors to understand the evolving dynamics of Elevance Health’s business model and its potential impact on future financial performance.

To gain further insights into Elevance Health Inc. (ELV) and its investor profile, consider exploring: Exploring Elevance Health Inc. (ELV) Investor Profile: Who’s Buying and Why?

Elevance Health Inc. (ELV) Profitability Metrics

Understanding Elevance Health Inc.'s profitability requires a close look at its gross profit, operating profit, and net profit margins. These metrics reveal how efficiently the company generates profit from its revenue and manages its expenses. Additionally, comparing these profitability ratios with industry averages provides valuable insights into Elevance Health Inc.'s competitive positioning and financial health. Investors should also closely monitor the trends in profitability over time to assess the company's ability to sustain and grow its earnings. For an overview of who is investing in Elevance Health, check out Exploring Elevance Health Inc. (ELV) Investor Profile: Who’s Buying and Why?

Here's a breakdown of key profitability metrics for Elevance Health:

  • Gross Profit Margin: This ratio indicates the percentage of revenue remaining after deducting the cost of goods sold (COGS). A higher gross profit margin suggests that Elevance Health Inc. is efficient in managing its production costs.
  • Operating Profit Margin: This ratio measures the percentage of revenue remaining after deducting both COGS and operating expenses. It reflects the company's profitability from its core business operations.
  • Net Profit Margin: This ratio represents the percentage of revenue that translates into net income. It is a comprehensive measure of overall profitability, taking into account all expenses, including interest and taxes.

Analyzing trends in these profitability metrics over the past few years can reveal important insights into Elevance Health Inc.'s performance. For example, consistent improvement in operating profit margin may indicate effective cost management and operational efficiency.

A comparison of Elevance Health Inc.'s profitability ratios with industry averages can highlight its competitive advantages and disadvantages. If Elevance Health Inc.'s net profit margin consistently outperforms its peers, it may suggest superior efficiency or a differentiated business model.

Operational efficiency plays a critical role in Elevance Health Inc.'s profitability. Effective cost management and favorable gross margin trends can significantly impact the bottom line. Investors should monitor these factors closely to assess the company's ability to maintain and improve its profitability.

To illustrate Elevance Health Inc.'s financial performance, the following table presents key financial data from recent years:

Financial Metric 2021 2022 2023 2024
Revenue (in millions) $138,646 $156,596 $168,781 $170,206
Gross Profit (in millions) $27,442 $30,998 $33,496 $33,787
Operating Income (in millions) $7,612 $8,249 $7,177 $7,246
Net Income (in millions) $6,065 $6,024 $5,441 $5,492

Based on the 2024 fiscal year data, Elevance Health Inc. reported revenues of $170,206 million, a gross profit of $33,787 million, an operating income of $7,246 million, and a net income of $5,492 million.

Elevance Health Inc. (ELV) Debt vs. Equity Structure

Understanding Elevance Health Inc.'s financial strategies involves a close examination of its debt and equity mix. This balance is crucial as it influences the company's financial stability and growth potential. Let’s delve into the specifics of Elevance Health Inc.'s debt levels, debt-to-equity ratio, and how it manages its financing.

Elevance Health Inc. strategically uses debt to fund its operations and growth initiatives. A look at the company's financial statements reveals the following about its debt profile:

  • Long-term Debt: Elevance Health Inc. carries a substantial amount of long-term debt, which is typical for companies in capital-intensive industries. As of fiscal year 2024, the long-term debt stood at $18.7 billion.
  • Short-term Debt: The company also utilizes short-term debt, which includes obligations due within a year. This type of debt helps manage immediate financial needs and operational expenses.

The debt-to-equity ratio is a key metric to assess Elevance Health Inc.'s financial leverage. As of 2024, Elevance Health Inc. reported a debt-to-equity ratio of approximately 0.72. This ratio indicates that for every dollar of equity, the company holds $0.72 in debt.

Here’s a comparison of Elevance Health Inc.'s debt-to-equity ratio with industry standards:

Company Debt-to-Equity Ratio (2024)
Elevance Health Inc. 0.72
Industry Average 0.50 - 1.00

Elevance Health Inc.'s debt-to-equity ratio falls within the typical range for its industry, suggesting a balanced approach to financial leverage.

Recent activities in debt management provide insights into Elevance Health Inc.'s financial strategy:

  • Debt Issuances: In the recent fiscal year, Elevance Health Inc. has strategically issued debt to capitalize on favorable interest rates, securing additional capital for investments and acquisitions.
  • Credit Ratings: Elevance Health Inc. holds strong credit ratings from major agencies, reflecting its creditworthiness and ability to manage debt effectively.
  • Refinancing: The company actively refinances its debt to lower interest expenses and extend maturity dates, optimizing its capital structure.

Elevance Health Inc. employs a balanced approach to financing its growth, strategically using both debt and equity. Debt financing allows Elevance Health Inc. to leverage opportunities without diluting equity. Equity funding, on the other hand, provides a stable capital base and reduces financial risk. The company's approach ensures it can invest in innovation, strategic acquisitions, and shareholder returns, fostering long-term growth and stability.

To gain more insight into Elevance Health Inc.'s values and goals, check out: Mission Statement, Vision, & Core Values of Elevance Health Inc. (ELV).

Elevance Health Inc. (ELV) Liquidity and Solvency

Analyzing Elevance Health Inc.'s financial health involves a close examination of its liquidity and solvency positions. These metrics provide insights into the company's ability to meet its short-term and long-term obligations.

Liquidity Ratios:

As of fiscal year 2024, key liquidity ratios for Elevance Health Inc. include:

  • Current Ratio: The current ratio, calculated by dividing current assets by current liabilities, offers a view of Elevance Health’s ability to cover its short-term liabilities with its short-term assets.
  • Quick Ratio: The quick ratio, which excludes inventories from current assets, provides a more conservative measure of short-term liquidity.

An upward trend in these ratios generally indicates improving liquidity, while a downward trend could signal potential concerns.

Working Capital Trends:

Monitoring the trend in Elevance Health's working capital—the difference between its current assets and current liabilities—is crucial. A positive working capital balance indicates that the company has enough liquid assets to cover its short-term liabilities. Declining working capital may suggest difficulties in meeting near-term obligations. The components of working capital, such as accounts receivable, accounts payable, and inventory levels, should also be analyzed for efficiency.

Cash Flow Statements Overview:

Elevance Health's cash flow statements provide a detailed look at the company's cash inflows and outflows, categorized into operating, investing, and financing activities. Here’s what to look for:

  • Operating Cash Flow: Positive and growing operating cash flow is a sign of a healthy core business.
  • Investing Cash Flow: This section includes cash used for investments in assets. Significant outflows in this area could indicate substantial capital expenditures.
  • Financing Cash Flow: This covers activities related to debt, equity, and dividends.

Potential Liquidity Concerns or Strengths:

Any substantial changes in these cash flow trends should be investigated. For instance, a decrease in operating cash flow coupled with an increase in debt could raise concerns about Elevance Health’s ability to meet its financial obligations. Conversely, strong operating cash flow and a healthy cash balance would be seen as strengths, enhancing the company’s financial flexibility.

For additional insights into Elevance Health Inc.'s strategic objectives, explore Mission Statement, Vision, & Core Values of Elevance Health Inc. (ELV).

Elevance Health Inc. (ELV) Valuation Analysis

Determining whether Elevance Health Inc. (ELV) is overvalued or undervalued requires a multifaceted approach, incorporating key financial ratios, stock performance analysis, and analyst sentiment. These factors, when assessed together, provide a comprehensive view of the company's valuation.

Key valuation ratios offer a snapshot of how the market perceives Elevance Health Inc. (ELV) relative to its financial performance:

  • Price-to-Earnings (P/E) Ratio: This ratio indicates how much investors are willing to pay for each dollar of Elevance Health Inc. (ELV)'s earnings. A higher P/E ratio might suggest overvaluation, while a lower one could indicate undervaluation, relative to industry peers or the company’s historical average.
  • Price-to-Book (P/B) Ratio: The P/B ratio compares Elevance Health Inc. (ELV)'s market capitalization to its book value of equity. It can help investors determine whether the stock price is justified by the company's net asset value.
  • Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: This ratio assesses the total value of Elevance Health Inc. (ELV), including debt, against its earnings before interest, taxes, depreciation, and amortization (EBITDA). It provides a clearer picture of valuation, irrespective of capital structure or accounting practices.

Analyzing Elevance Health Inc. (ELV)'s stock price trends over the last 12 months (or longer) offers insights into market sentiment and investor confidence. A consistent upward trend may reflect positive expectations, while volatility could indicate uncertainty or changing market conditions. For example, Elevance Health Inc. (ELV) [ELV] had a 52 week high of $568.39 and a 52 week low of $416.42. As of April 18, 2024, the stock was trading at $520.26.

Dividend yield and payout ratios are particularly relevant for investors seeking income. Elevance Health Inc. (ELV)'s dividend yield indicates the annual dividend income relative to its stock price, while the payout ratio shows the proportion of earnings distributed as dividends. A sustainable dividend yield and a reasonable payout ratio can signal financial stability and a commitment to shareholder returns. Elevance Health Inc. (ELV) has a dividend yield of 1.27%. The most recent dividend payout was on March 8, 2024 for $1.63.

Analyst consensus provides a summarized view of professional opinions on Elevance Health Inc. (ELV)'s stock valuation. Ratings such as 'buy,' 'hold,' or 'sell' reflect analysts' expectations for the stock's future performance. These ratings, along with price targets, offer valuable guidance for investors, although they should be considered as just one component of a comprehensive analysis.

Here's a snapshot of recent analyst ratings for Elevance Health Inc. (ELV):

Date Firm Action Rating
2024-04-19 BMO Capital Maintains Outperform
2024-04-19 Raymond James Maintains Strong Buy
2024-04-19 Truist Securities Maintains Buy
2024-04-18 UBS Maintains Buy

For more insights into Elevance Health Inc. (ELV) and its investors, check out: Exploring Elevance Health Inc. (ELV) Investor Profile: Who’s Buying and Why?

Elevance Health Inc. (ELV) Risk Factors

Elevance Health Inc. (ELV) faces a variety of internal and external risks that could significantly impact its financial health. These risks span across industry competition, regulatory changes, and broader market conditions.

Industry Competition: The health insurance industry is highly competitive. Elevance Health Inc. faces competition from other large national players, regional health plans, and smaller, niche market insurers. This intense competition can pressure profit margins as companies vie for market share through competitive pricing and benefit offerings. Maintaining a competitive edge requires continuous investment in innovation, technology, and customer service.

Regulatory Changes: The healthcare industry is heavily regulated, and changes in laws and regulations can have a profound impact on Elevance Health Inc.’s operations and financial performance. Key regulatory risks include:

  • Affordable Care Act (ACA): Changes to the ACA, including potential modifications to subsidies or coverage mandates, could significantly alter the size and composition of the insured population, affecting Elevance Health Inc.’s enrollment and revenue.
  • Medicare and Medicaid: As a major provider of Medicare and Medicaid plans, Elevance Health Inc. is exposed to changes in government funding levels, reimbursement rates, and eligibility requirements. Reductions in funding or unfavorable changes in payment policies could negatively impact profitability.
  • State Regulations: State-level regulations regarding insurance coverage, provider networks, and other aspects of healthcare delivery can vary significantly and create compliance challenges for Elevance Health Inc., which operates in multiple states.

Market Conditions: Economic downturns, rising healthcare costs, and demographic shifts can all affect Elevance Health Inc.’s financial performance. For example:

  • Economic Downturns: During economic recessions, individuals may lose employer-sponsored health insurance, leading to declines in commercial enrollment. Additionally, states may face budget pressures that could lead to reduced Medicaid funding.
  • Rising Healthcare Costs: The increasing cost of medical services and prescription drugs is a persistent challenge for health insurers. Elevance Health Inc. must effectively manage these costs while maintaining affordable premiums for its members.
  • Demographic Shifts: Changes in the age and health status of the population can impact Elevance Health Inc.’s risk profile and healthcare costs. For example, an aging population may require more healthcare services, increasing costs.

Operational, Financial, and Strategic Risks: Recent earnings reports and filings highlight several operational, financial, and strategic risks. These include:

  • Cybersecurity Threats: Elevance Health Inc. handles a vast amount of sensitive patient data, making it a target for cyberattacks. A successful cyberattack could result in data breaches, reputational damage, and significant financial losses.
  • Integration Risks: As Elevance Health Inc. continues to grow through acquisitions, it faces the risk of failing to successfully integrate acquired businesses. Integration challenges can lead to operational inefficiencies, loss of key personnel, and failure to achieve expected synergies.
  • Investment Portfolio Performance: Fluctuations in the financial markets can impact the performance of Elevance Health Inc.’s investment portfolio, affecting its overall financial results. Prudent investment management is essential to mitigate this risk.

Mitigation Strategies: Elevance Health Inc. employs various strategies to mitigate these risks:

  • Diversification: Diversifying its business across different segments (e.g., commercial, Medicare, Medicaid) and geographies helps to reduce Elevance Health Inc.’s reliance on any single market or product.
  • Cost Management: Implementing cost-saving initiatives, such as negotiating favorable contracts with providers and promoting the use of generic drugs, helps to control healthcare costs.
  • Compliance Programs: Maintaining robust compliance programs to ensure adherence to all applicable laws and regulations helps to minimize legal and regulatory risks.
  • Cybersecurity Investments: Investing in advanced cybersecurity technologies and training programs helps to protect against cyber threats and data breaches.

Understanding these risks and mitigation strategies is crucial for investors assessing Elevance Health Inc.’s financial health and long-term prospects. Further insights into Elevance Health Inc. (ELV) can be found here: Exploring Elevance Health Inc. (ELV) Investor Profile: Who’s Buying and Why?

Elevance Health Inc. (ELV) Growth Opportunities

Elevance Health Inc. (ELV) demonstrates promising future growth prospects driven by several key factors, including strategic initiatives, market expansions, and innovative solutions.

Key Growth Drivers:

  • Product Innovations: Elevance Health is focused on developing and implementing innovative healthcare solutions, such as virtual primary care and digital health platforms. These innovations aim to improve patient access, enhance care coordination, and drive better health outcomes.
  • Market Expansion: Elevance Health continues to expand its market presence through organic growth and strategic acquisitions. This includes expanding its government business, which serves Medicaid and Medicare beneficiaries, and growing its commercial business by offering competitive and comprehensive health plans.
  • Acquisitions and Partnerships: Elevance Health strategically acquires companies and forms partnerships to enhance its capabilities and expand its service offerings. These collaborations enable Elevance Health to offer a broader range of healthcare services and solutions to its members.

Future Revenue Growth Projections and Earnings Estimates:

Analysts predict continued revenue growth for Elevance Health, driven by increasing demand for its services and strategic initiatives. While specific long-term revenue growth projections vary among analysts, the consensus is that Elevance Health is well-positioned to achieve consistent growth in the coming years. For the fiscal year 2024, Elevance Health anticipates adjusted net income to be greater than $37.10 per share.

Strategic Initiatives and Partnerships:

  • Carelon: Elevance Health's health services division, Carelon, is focused on providing integrated care solutions that address the physical, behavioral, and social drivers of health. Carelon's comprehensive approach aims to improve health outcomes and lower healthcare costs.
  • Digital Health Platforms: Elevance Health is investing in digital health platforms to enhance member engagement and provide personalized healthcare experiences. These platforms offer features such as virtual care, remote monitoring, and personalized health coaching.
  • Partnerships with Healthcare Providers: Elevance Health collaborates with healthcare providers to develop innovative care models and improve care coordination. These partnerships aim to deliver value-based care that rewards quality and outcomes.

Competitive Advantages:

  • Scale and Market Presence: Elevance Health is one of the largest health insurance companies in the United States, with a significant market presence and a large membership base. This scale provides Elevance Health with a competitive advantage in negotiating rates with healthcare providers and managing healthcare costs.
  • Diversified Business Model: Elevance Health's diversified business model, which includes commercial, government, and health services segments, provides stability and reduces risk. This diversification allows Elevance Health to weather economic cycles and adapt to changing market conditions.
  • Focus on Innovation: Elevance Health's commitment to innovation and technology enables it to develop and implement cutting-edge healthcare solutions. This focus on innovation helps Elevance Health differentiate itself from competitors and attract and retain members.

Elevance Health Inc. (ELV) is strategically positioned for sustained growth, driven by its innovative solutions, market expansions, and strategic partnerships. The company's focus on integrated care, digital health, and value-based care models positions it to capitalize on emerging trends in the healthcare industry and deliver long-term value to its shareholders.

Read more about Elevance Health Inc. (ELV) Financial Health: Breaking Down Elevance Health Inc. (ELV) Financial Health: Key Insights for Investors

DCF model

Elevance Health Inc. (ELV) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.